Member of Lyonbiopole
Fab’entech is a privately owned biopharmaceutical SME developing immunotherapies to address situations of emergency. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease.
Strategic application domain: Human Medicine
Application market: Infectious Diseases, Others
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Antibodies - Protein - Peptide
Created on june 3rd, 2009 - 39 employees
Address
24, rue Jean Baldassini 69007 LYON
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.
